Zymergen (NASDAQ:ZY) and National Research (NASDAQ:NRC) Financial Comparison

Zymergen (NASDAQ:ZYGet Rating) and National Research (NASDAQ:NRCGet Rating) are both small-cap basic materials companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings.

Valuation and Earnings

This table compares Zymergen and National Research’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Zymergen $16.74 million 8.38 -$361.79 million ($9.53) -0.14
National Research $147.95 million 5.53 $37.47 million $1.45 22.40

National Research has higher revenue and earnings than Zymergen. Zymergen is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Zymergen and National Research’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Zymergen -2,160.81% -213.99% -64.50%
National Research 24.36% 45.06% 23.69%

Insider and Institutional Ownership

68.4% of Zymergen shares are held by institutional investors. Comparatively, 69.2% of National Research shares are held by institutional investors. 2.0% of National Research shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Analyst Ratings

This is a summary of current recommendations and price targets for Zymergen and National Research, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zymergen 3 5 0 0 1.63
National Research 0 0 0 0 N/A

Zymergen currently has a consensus target price of $6.75, suggesting a potential upside of 396.32%. Given Zymergen’s higher possible upside, research analysts plainly believe Zymergen is more favorable than National Research.

Summary

National Research beats Zymergen on 9 of the 11 factors compared between the two stocks.

Zymergen Company Profile (Get Rating)

Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California.

National Research Company Profile (Get Rating)

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.

Receive News & Ratings for Zymergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zymergen and related companies with MarketBeat.com's FREE daily email newsletter.